Evidence map›Paper›PMID 36913364›Full record

ArticlePloS one2023

Fetoscopic endoluminal tracheal occlusion with Smart-TO balloon: Study protocol to evaluate effectiveness and safety of non-invasive removal.

Nicolas Sananès, David Basurto, Anne-Gaël Cordier, Caroline Elie, Francesca Maria Russo, Alexandra Benachi, Jan Deprest

Open access · goldFull text read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Using simulation to prepare multidisciplinary teams and clinical environments for complex fetal interventions and resuscitation.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nicolas SananèsDepartment of Maternal Fetal Medicine, Strasbourg University Hospital, Strasbourg, France.ORCID 0000-0002-0461-8428
David BasurtoMyFetUZ Fetal Research Center, Department of Development and Regeneration, Cluster Woman and Child, Biomedical Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-2022-9027
Anne-Gaël CordierDepartment of Maternal fetal Medicine, Antoine-Béclère Hospital - Paris-Saclay University, Clamart, France.
Caroline ElieClinical Research Unit/Clinical Investigation Center, Necker-Enfants Malades Hospital, Paris, France.
Francesca Maria RussoMyFetUZ Fetal Research Center, Department of Development and Regeneration, Cluster Woman and Child, Biomedical Sciences, KU Leuven, Leuven, Belgium.
Alexandra BenachiDepartment of Maternal fetal Medicine, Antoine-Béclère Hospital - Paris-Saclay University, Clamart, France.
Jan DeprestMyFetUZ Fetal Research Center, Department of Development and Regeneration, Cluster Woman and Child, Biomedical Sciences, KU Leuven, Leuven, Belgium.
KU Leuven · BEUniversité Paris-Saclay · FRInserm · FRLondon Women's Clinic · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOne of the drawbacks of fetoscopic endoluminal tracheal occlusion (FETO) for congenital diaphragmatic hernia is the need for a second invasive intervention to reestablish airway patency. The "Smart-TO" (Strasbourg University-BSMTI, France) is a new balloon for FETO, which spontaneously deflates when positioned near a strong magnetic field, e.g., generated by a magnetic resonance image (MRI) scanner. Translational experiments have demonstrated its efficacy and safety. We will now use the Smart-TO balloon for the first time in humans. Our main objective is to evaluate the effectiveness of prenatal deflation of the balloon by the magnetic field generated by an MRI scanner. MATERIAL AND

methodsThese studies were first in human (patients) trials conducted in the fetal medicine units of Antoine-Béclère Hospital, France, and UZ Leuven, Belgium. Conceived in parallel, protocols were amended by the local Ethics Committees, resulting in some minor differences. These trials were single-arm interventional feasibility studies. Twenty (France) and 25 (Belgium) participants will have FETO with the Smart-TO balloon. Balloon deflation will be scheduled at 34 weeks or earlier if clinically required. The primary endpoint is the successful deflation of the Smart-TO balloon after exposure to the magnetic field of an MRI. The secondary objective is to report on the safety of the balloon. The percentage of fetuses in whom the balloon is deflated after exposure will be calculated with its 95% confidence interval. Safety will be evaluated by reporting the nature, number, and percentage of serious unexpected or adverse reactions.

conclusionThese first in human (patients) trials may provide the first evidence of the potential to reverse the occlusion by Smart-TO and free the airways non-invasively, as well a safety data.

Indexed as

Airway ObstructionBalloon OcclusionHernias, Diaphragmatic, CongenitalFemaleFetoscopyFetusHumansPerinatologyPregnancyTrachea

Identifiers

PMID36913364
PMCPMC10010565
OpenAlexW4324019083

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read45
identifiers read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.